Professional Summary
Professional Overview
Whitney Cavanagh is a seasoned biopharma executive with over 15 years of experience in portfolio and program management. As the VP of Portfolio & Program Management at Brii Biosciences and Zenas BioPharma, she leverages her in-depth expertise to drive the strategic planning and successful execution of complex biopharmaceutical development programs.
Experience Summary
Current Roles
VP, Portfolio & Program Management, Brii Biosciences (2023-01-01 to Present)
- Responsible for leading the strategic planning and management of the company's diverse portfolio of drug candidates and programs
- Oversees cross-functional teams to ensure efficient and effective project execution, delivering on key milestones and timelines
- Collaborates with executive leadership to optimize resource allocation and align pipeline development with the company's strategic objectives
VP, Portfolio & Program Management, Zenas BioPharma (2021-08-01 to Present)
- Provides strategic direction and operational oversight for the company's portfolio of clinical-stage assets
- Implements robust program management processes to drive the successful progression of multiple development programs
- Fosters strong partnerships with internal and external stakeholders to facilitate seamless program execution
Career Progression
Vice President Program Management, Sio Gene Therapies (2018-01-01 to 2021-09-01)
- Led the strategic planning and implementation of the company's gene therapy pipeline, including the successful advancement of multiple programs into clinical development
- Developed and optimized program management frameworks to enhance cross-functional collaboration and ensure efficient project delivery
Head of Integrated Evidence Planning, UCB (2016-01-01 to 2018-01-01)
- Spearheaded the development of comprehensive evidence generation strategies to support the clinical and regulatory progression of the company's drug candidates
- Collaborated with cross-functional teams to align on data requirements and effectively communicate program updates to internal and external stakeholders
Head of Project Management, Chimerix, Inc. (2011-01-01 to 2016-01-01)
- Oversaw the successful execution of multiple clinical development programs, driving projects from early-stage to late-stage trials
- Implemented robust project management methodologies to optimize resource allocation, mitigate risks, and ensure timely delivery of key milestones
Academic Background
Whitney Cavanagh holds a Master of Science in Biotechnology from the University of North Carolina at Chapel Hill, where she specialized in pharmaceutical development and regulatory affairs.
Areas of Expertise
- Biopharma portfolio and program management
- Strategic planning and resource optimization
- Cross-functional team leadership and collaboration
- Regulatory and clinical trial management
- Stakeholder engagement and effective communication
Professional Impact
- Spearheaded the successful advancement of multiple gene therapy and small molecule drug candidates through clinical development
- Implemented innovative program management frameworks that improved execution efficiency and enhanced cross-functional coordination
- Played a pivotal role in securing regulatory approvals and enabling the market launch of several biopharmaceutical products
Conclusion
With her extensive experience in portfolio and program management, Whitney Cavanagh has established herself as a respected leader in the biopharmaceutical industry. Her strategic vision, operational expertise, and commitment to driving the successful development of innovative therapies make her a valuable asset to Brii Biosciences and Zenas BioPharma as they continue to advance their drug pipelines and make a meaningful impact on patient lives.
